Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FSA bill rollover to Senate

This article was originally published in The Tan Sheet

Executive Summary

"HEALTH Act of 2004," which would revise flexible spending account programs to allow more employees using FSAs to rollover up to $500 in unused funds at the end of a year, was placed on the calendar in the Senate May 20 after passing the House last week. CHPA applauded HR 4279, which would make the accounts more appealing to employees unsure about how much they might spend. The association supported an IRS ruling last year which allowed reimbursement of over-the-counter drugs under FSAs (1"The Tan Sheet" Sept. 8, 2003, p. 3)...

You may also be interested in...

IRS Rule On Flex-Spending Accounts A Boon For Chronic-Use OTCs, Switches

Schering-Plough's Claritin and Procter & Gamble's Prilosec OTC are likely to be major beneficiaries of an IRS ruling that nonprescription drugs can be covered by employee health flexible spending arrangements

EU MDR Notified Body Designations Could Soar By A Third By End Of 2021

There could be 28 notified body designations in total under the Medical Device Regulation by the end of 2021. But there is cause for concern over designations under the IVD Regulation, which are lagging far behind.

Swiss Health Providers Turn Heat On Federal Council: 12% Loss Of Medtech Products Likely On EU MRA Failure

A consortium of Swiss providers, patient groups and health care trade bodies is imploring the federal council to avert a looming patient care crisis in Switzerland if the EU MRA cannot be agreed.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts